Yangxia Wang, M.S.

Yangxia Wang obtained her bachelor's degree from Xiangya School of Medicine at Central South University, Changsha, China. She then pursued further studies at the University of Ottawa, Canada, where she worked in Dr. William Stanford's laboratory. During this period, Yangxia made significant progress on a challenging project that utilized induced pluripotent stem cells to model Tuberous Sclerosis Complex and Lymphangioleiomyomatosis. Concurrently, she volunteered at the Ottawa Heart Institute, contributing to data entry and analysis.

Subsequently, Yangxia transitioned to clinical diagnostic work at the First Affiliated Hospital of Zhengzhou University, China, where she obtained a master's degree. In 2022, she was awarded a Provincial Health Commission Co-construction Project Fund, an advanced individual award, and recognition as an outpatient service model worker. Yangxia's passion lies in clinical diagnostic biomarkers, particularly those related to early-stage disease detection in blood samples, encompassing both basic research and clinical translation.

Her research on exosomal circRNAs has been published in Molecular Cancer, and she has served as a peer reviewer for multiple circRNA-related articles in the Journal of Experimental and Clinical Cancer Research. Driven by a desire to delve deeper into the realm of exosomal blood biomarkers, Yangxia joined the Bitan laboratory where she is primarily involved in research on blood biomarkers for various neurodegenerative diseases.